| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.091 | 0.006 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.007 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.008 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.099 | 0.008 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.097 | 0.008 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.008 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.15 | 0.009 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.097 | 0.01 |